Latest news
Tonix Gets FDA Alignment on TNX-4800 Phase 2 Lyme Disease Study Design - The Clinical Trial VanguardThe Clinical Trial Vanguard · Wed, 05 Aug 2026 06:33:35 GMTRuto's privatisation push boosts forex reserves to record $15.4b - standardmedia.co.kestandardmedia.co.ke · Tue, 04 Aug 2026 04:00:00 GMTSmarter water technologies hold the key to ending Africa's hunger crisis - standardmedia.co.kestandardmedia.co.ke · Tue, 04 Aug 2026 03:00:00 GMTTonix Plans Two-Dose Antibody Study; Protection Expected in 2 Days - Stock TitanStock Titan · Mon, 03 Aug 2026 11:00:00 GMTFrom Fibromyalgia to Depression: TNX-102 Sublingual Cyclobenzaprine Trials for MDD - Psychiatric TimesPsychiatric Times · Thu, 30 Jul 2026 07:00:00 GMTTNX-102 SL in Major Depressive Disorder: Targeting Slow-Wave Sleep - Psychiatric TimesPsychiatric Times · Wed, 29 Jul 2026 07:00:00 GMTTNXP|Tonix Pharmaceuticals Holding Corp|Price:11.230|Chg%:+0.565 - TradingKeyTradingKey · Mon, 27 Jul 2026 12:05:49 GMTTonix Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 10, 2026 - The Manila TimesThe Manila Times · Mon, 27 Jul 2026 11:17:10 GMT